Adverse Effects and Toxicity Management
Start with the big picture
A central theme is recognizing toxicity patterns linked to particular agents: cisplatin is associated with kidney and hearing effects, anthracyclines and trastuzumab with cardiac effects, and bleomycin with pulmonary fibrosis. The topic also covers myelosuppression, hemorrhagic cystitis, methotrexate toxicity, neuropathy, skin reactions, and immune-mediated adverse events. Management approaches include supportive care, preventive measures, monitoring, and selected rescue treatments. Serious complications such as tumor lysis syndrome and secondary malignancies are also addressed, alongside highly emetogenic chemotherapy and monoclonal antibody infusion reactions. Together, these concepts help connect drug-specific risks with practical safety strategies.
What you'll learn
- Identify common chemotherapy toxicities and the drug classes associated with them.
- Describe approaches to preventing and managing myelosuppression and febrile neutropenia.
- Recognize organ-specific toxicities involving the kidneys, heart, lungs, bladder, and nervous system.
- Summarize prevention and management strategies for selected treatment-related complications.
- Distinguish immune-mediated adverse events from other chemotherapy toxicities.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
